MX2009005764A - Metodo para producir polipeptidos libres de metionina n-terminal en celulas huesped microbianas. - Google Patents
Metodo para producir polipeptidos libres de metionina n-terminal en celulas huesped microbianas.Info
- Publication number
- MX2009005764A MX2009005764A MX2009005764A MX2009005764A MX2009005764A MX 2009005764 A MX2009005764 A MX 2009005764A MX 2009005764 A MX2009005764 A MX 2009005764A MX 2009005764 A MX2009005764 A MX 2009005764A MX 2009005764 A MX2009005764 A MX 2009005764A
- Authority
- MX
- Mexico
- Prior art keywords
- microbial host
- terminal
- methioine
- producing
- host cells
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 230000000813 microbial effect Effects 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 229930182817 methionine Natural products 0.000 abstract 2
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 1
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 1
- 239000000854 Human Growth Hormone Substances 0.000 abstract 1
- 108091005804 Peptidases Proteins 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 108010023197 Streptokinase Proteins 0.000 abstract 1
- 230000004186 co-expression Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 229960005202 streptokinase Drugs 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3153—Streptokinase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se describe un método para elaborar un polipéptido libre de metionina N-terminal en una célula huésped microbiana recombinante y composiciones farmacéuticas junto con uno o más excipientes farmacéuticos para el manejo de varios trastornos terapéuticos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2217CH2006 | 2006-11-30 | ||
PCT/IN2007/000012 WO2008065673A1 (en) | 2006-11-30 | 2007-01-12 | A method for producing n-terminal methioine free polypeptides in microbial host cells |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009005764A true MX2009005764A (es) | 2009-08-24 |
Family
ID=39467497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009005764A MX2009005764A (es) | 2006-11-30 | 2007-01-12 | Metodo para producir polipeptidos libres de metionina n-terminal en celulas huesped microbianas. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2097520A4 (es) |
MX (1) | MX2009005764A (es) |
WO (1) | WO2008065673A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102533712A (zh) * | 2009-05-12 | 2012-07-04 | 中国科学院上海生命科学研究院 | 一种固相化sumo化系统及固相化去sumo化系统 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5763215A (en) * | 1984-08-16 | 1998-06-09 | Bio-Technology General Corporation | Method of removing N-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced thereby |
KR970010135B1 (ko) * | 1993-06-17 | 1997-06-21 | 주식회사 엘지화학 | 신규 아미노펩티다제 |
KR100369839B1 (ko) * | 1997-02-28 | 2003-06-12 | 주식회사 엘지생명과학 | 바실러스리케니포미스균주에서유래한아미노펩티다제,그의제조방법및이를이용한천연형단백질의제조방법 |
ATE380878T1 (de) * | 2002-01-07 | 2007-12-15 | Lifesensors Inc | Verfahren und zusammensetzungen für die proteinexpression und reinigung |
US7109015B2 (en) * | 2004-03-29 | 2006-09-19 | Academia Sinica | Removal of N-terminal methionine from proteins by engineered methionine aminopeptidase |
EP1836214A4 (en) * | 2004-12-30 | 2009-01-21 | Lifesensors Inc | COMPOSITIONS, METHODS, AND KITS FOR IMPROVING PROTEIN EXPRESSION, SOLUBILITY, AND ISOLATION |
-
2007
- 2007-01-12 MX MX2009005764A patent/MX2009005764A/es active IP Right Grant
- 2007-01-12 WO PCT/IN2007/000012 patent/WO2008065673A1/en active Application Filing
- 2007-01-12 EP EP07706183A patent/EP2097520A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2097520A1 (en) | 2009-09-09 |
WO2008065673A1 (en) | 2008-06-05 |
EP2097520A4 (en) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ596037A (en) | Fgf21 mutants and uses thereof | |
MX2011008094A (es) | Polipeptidos recombinantes extendidos y composiciones que comprenden los mismos. | |
MX2011013183A (es) | Polipeptidos de la hormona de crecimiento y metodos de preparacion y su uso. | |
NZ601592A (en) | Recombinant elastase proteins and methods of manufacturing and use thereof | |
WO2006136084A8 (fr) | Proteines de fusion de proteines structurales recombinantes du coronavirus sars, leur production et leurs utilisations | |
EP2175834B8 (en) | Glp-1-fc fusion protein formulation | |
GB0713656D0 (en) | Modified human growth hormone | |
IN2012DN02764A (es) | ||
TN2015000053A1 (en) | Fusion proteins for treating a metabolic syndrome | |
MX2010002716A (es) | Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago. | |
MX2011011130A (es) | Proteina o peptido de fusion con vida media in vivo incrementada mantenido por liberacion in vivo sostenida, y metodo para incrementar la vida media in vivo usando el mismo. | |
UA103215C2 (uk) | Поліпептид з ксиланазною активністю | |
WO2011084808A3 (en) | Bifunctional polypeptide compositions and methods for treatment of metabolic and cardiovascular diseases | |
MX2011007583A (es) | Nuevas formulaciones estables de proteina de fusion recombinante de albumina humana-factor humano de estimulacion de colonias de granulocitos. | |
CY1110734T1 (el) | Μεθοδος παραγωγης μονιμων ανθρωπινων κυτταρικων σειρων | |
IN2014DN02043A (es) | ||
MY181496A (en) | Smoothened polypeptides and methods of use | |
DE60332358D1 (de) | Protease-resistente modifizierte interferon alpha polypeptide | |
NZ750556A (en) | Delivery of mrna for the augmentation of proteins and enzymes in human genetic diseases | |
AR075029A1 (es) | Metodo para producir una proteina o un peptido fisiologicamente activo usando un fragmento de inmunoglobulina | |
ZA200800517B (en) | Transplastomic plants expressing lumen-targeted protein | |
NZ598176A (en) | Disintegrin variants and pharmaceutical uses thereof | |
NZ733113A (en) | Methods of producing long acting ctp-modified growth hormone polypeptides | |
GB2455262A (en) | Methods for production of recombinant plasminogen and plasmin polypeptides | |
MX2020013296A (es) | Composiciones que contienen inhibidor de proteasa recombinante, metodos para producir las mismas y usos de las mismas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |